Study of Gemcitabine and Abraxane to Treat Potentially Operable Pancreatic Cancer

NCT01298011 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

25

Enrollment

OTHER

Sponsor class

Conditions

Resectable Pancreatic Cancer

Interventions

DRUG: Gemcitabine and Abraxane

Sponsor

Pancreatic Cancer Research Team

Collaborators

[object Object]